Clinical Trials Directory

Trials / Sponsors / Ophthotech Corporation

Ophthotech Corporation

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
Idiopathic Polypoidal Choroidal Vasculopathy
Phase 22018-11-01
CompletedZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)
Neovascular Age-related Macular Degeneration
Phase 22017-10-11
TerminatedA 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Adminis
Age-Related Macular Degeneration
Phase 22016-04-26
CompletedA Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Th
Idiopathic Polypoidal Choroidal Vasculopathy
Phase 22015-03-12
TerminatedPhase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF
Age-related Macular Degeneration
Phase 22014-07-01
TerminatedA Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Eith
Age-Related Macular Degeneration
Phase 32014-05-01
TerminatedA Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Luce
Age-Related Macular Degeneration
Phase 32013-08-01
TerminatedA Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Luce
Age-Related Macular Degeneration
Phase 32013-08-01
CompletedA Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related
Age-Related Macular Degeneration
Phase 22010-03-01
CompletedA Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration
Dry Age-Related Macular Degeneration
Phase 12009-07-16
CompletedARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular Degenerati
Neovascular Age-Related Macular Degeneration
Phase 12008-10-16
CompletedA Phase 1 Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profil
Age-related Macular Degeneration
Phase 12008-10-01
CompletedA Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF P
Age-related Macular Degeneration
Phase 12007-12-01